These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8093103)

  • 1. Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase.
    O'Brien EM; Dostert P; Pevarello P; Tipton KF
    Biochem Pharmacol; 1994 Aug; 48(5):905-14. PubMed ID: 8093103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.
    O'Brien EM; Dostert P; Tipton KF
    Biochem Pharmacol; 1995 Jul; 50(3):317-24. PubMed ID: 7646533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of monoamine oxidase B by analogues of the anticonvulsant agent milacemide (2-(n-pentylamino)acetamide).
    Nishimura K; Lu X; Silverman RB
    J Med Chem; 1993 Feb; 36(4):446-8. PubMed ID: 8474100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interactions of milacemide with monoamine oxidase.
    O'Brien EM; Tipton KF; McCrodden JM; Youdim MB
    Biochem Pharmacol; 1994 Feb; 47(4):617-23. PubMed ID: 8129740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
    Janssens de Varebeke P; Cavalier R; David-Remacle M; Youdim MB
    J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions?
    O'Brien EM; Tipton KF; Strolin Benedetti M; Bonsignori A; Marrari P; Dostert P
    Biochem Pharmacol; 1991 Jun; 41(11):1731-7. PubMed ID: 2043162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAO activity, metabolism and anticonvulsant activity of milacemide in rats and mice.
    Colombo M; Strolin Benedetti M; Bonsignori A; Cocchiara G; Roncucci R; Dostert P
    J Neural Transm Suppl; 1990; 32():123-9. PubMed ID: 2089081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B.
    Janssens de Varebeke P; Pauwels G; Buyse C; David-Remacle M; De Mey J; Roba J; Youdim MB
    J Neurochem; 1989 Oct; 53(4):1109-16. PubMed ID: 2769256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
    Bonaiuto E; Milelli A; Cozza G; Tumiatti V; Marchetti C; Agostinelli E; Fimognari C; Hrelia P; Minarini A; Di Paolo ML
    Eur J Med Chem; 2013; 70():88-101. PubMed ID: 24140951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide?
    Strolin Benedetti M; Cocchiara G; Colombo M; Dostert P
    J Neural Transm Suppl; 1990; 32():351-6. PubMed ID: 2128509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors.
    Pozdnev VF; Kirkel AZ; Kamyshanskaya NS; Axenova LN; Medvedev AE
    J Neural Transm Suppl; 1998; 52():351-5. PubMed ID: 9564638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR analysis.
    Medvedev AE; Ramsay RR; Ivanov AS; Veselovsky AV; Shvedov VI; Tikhonova OV; Barradas AP; Davidson CK; Moskvitina TA; Fedotova OA; Axenova LN
    Neurobiology (Bp); 1999; 7(2):151-8. PubMed ID: 10591049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase inhibitory properties of milacemide in rats.
    Truong DD; Diamond B; Pezzoli G; Mena MA; Fahn S
    Life Sci; 1989; 44(15):1059-66. PubMed ID: 2784529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of monoamine oxidase B by aminoethyl substituted benzyl ethers.
    Woodroofe CC; Mostashari R; Lu X; Ramsay RR; Silverman RB
    J Enzyme Inhib; 2000; 15(1):11-21. PubMed ID: 10850952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 2-phenoxyacetamide analogues, a novel class of potent and selective monoamine oxidase inhibitors.
    Shen W; Yu S; Zhang J; Jia W; Zhu Q
    Molecules; 2014 Nov; 19(11):18620-31. PubMed ID: 25405283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
    Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some peculiar aspects of monoamine oxidase inhibition.
    Ramadan ZB; Dostert P; Tipton KF
    Neurobiology (Bp); 1999; 7(2):159-74. PubMed ID: 10591050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.
    Strydom B; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2010 Feb; 18(3):1018-28. PubMed ID: 20093036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.